Loading...
NAICSSector 32
U.S. imports of pharmaceutical preparations (NAICS 325412) totaled $6.9B in July 2026, traded with 68 countries.
Importers of Pharmaceutical Preparations paid $3.0M in duties in July 2026 — an effective duty rate of 9.2% on $32.8M in dutiable value, based on actual customs collections rather than the published tariff schedule.
Last updated: July 2026 dataFinished pharmaceutical preparations — including tablets, capsules, injectables, and topical formulations — represent one of the most tightly regulated import categories, with FDA admissibility review, foreign facility registration, and drug listing requirements all applying before a shipment can enter US commerce. The HTS classification of a preparation depends on its active ingredient, dosage form, and therapeutic category, and misclassification can trigger both duty underpayment issues and regulatory holds. Products subject to Section 301 tariffs based on origin add another layer of cost analysis for importers sourcing from affected countries. Serialization and traceability requirements under the Drug Supply Chain Security Act also apply to most finished prescription drug imports.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
19.3K shipments/mo
Under the Drug Supply Chain Security Act (DSCSA), most finished prescription drug products imported into the US must carry a product identifier — including a standardized numerical identifier, lot number, and expiration date — and trading partners must be able to exchange transaction information. Importers should confirm their foreign suppliers are DSCSA-compliant before shipment to avoid distribution chain disruptions.
HTS classification of pharmaceutical preparations is sensitive to dosage form (e.g., tablet vs. injectable vs. transdermal patch), active ingredient identity, and therapeutic use. Different dosage forms of the same active ingredient can fall under different tariff lines with different duty rates and Section 301 exposure. A licensed customs broker with pharmaceutical experience should review classification before import.
Supplier Network
Get discovered by U.S. importers searching for HS 325412 — Pharmaceutical Preparations. Be the first supplier listed.
National industry 1 of 4 in naics industry 32541
National industry 325412 · $6.9B of $15.9B
Imports · July 2026
origin
customs district
Census does not publish district detail for this classification system.
destination
None recorded for this period.
entry
Census does not publish port detail for this classification system.
ImportsExports
Imports
$6.9BYoY · Pro
Exports
$2.8BYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.